653 related articles for article (PubMed ID: 33964119)
1. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
Gu C; Wang F; Zhang YT; Wei SZ; Liu JY; Sun HY; Wang GH; Liu CF
Aging Cell; 2021 Jun; 20(6):e13375. PubMed ID: 33964119
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
3. RND3 modulates microglial polarization and alleviates neuroinflammation in Parkinson's disease by suppressing NLRP3 inflammasome activation.
Hu W; Wang M; Sun G; Zhang L; Lu H
Exp Cell Res; 2024 Jun; 439(1):114088. PubMed ID: 38744409
[TBL] [Abstract][Full Text] [Related]
4. Early glycolytic reprogramming controls microglial inflammatory activation.
Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
[TBL] [Abstract][Full Text] [Related]
5. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
[TBL] [Abstract][Full Text] [Related]
6. Microglial SIX2 suppresses lipopolysaccharide (LPS)-induced neuroinflammation by up-regulating FXYD2 expression.
Cao XY; Liu Y; Kan JS; Huang XX; Kambey PA; Zhang CT; Gao J
Brain Res Bull; 2024 Jun; 212():110970. PubMed ID: 38688414
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of IRF8 alleviates neuroinflammation through regulating microglial activation in Parkinson's disease.
Ma L; Mi N; Wang Z; Bao R; Fang J; Ren Y; Xu X; Zhang H; Tang Y
J Chem Neuroanat; 2024 Jul; 138():102424. PubMed ID: 38670441
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
13. Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway.
Sun HY; Wu J; Wang R; Zhang S; Xu H; Kaznacheyeva Е; Lu XJ; Ren HG; Wang GH
Acta Pharmacol Sin; 2023 Jun; 44(6):1135-1148. PubMed ID: 36536076
[TBL] [Abstract][Full Text] [Related]
14. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
Kim DY; Leem YH; Park JS; Park JE; Park JM; Kang JL; Kim HS
Cells; 2023 Jan; 12(3):. PubMed ID: 36766759
[TBL] [Abstract][Full Text] [Related]
15. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
16. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
17. 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
Song SY; Kim IS; Koppula S; Park JY; Kim BW; Yoon SH; Choi DK
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147699
[TBL] [Abstract][Full Text] [Related]
18. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
19. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation.
Yang R; Li DD; Li XX; Yang XX; Gao HM; Zhang F
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132179. PubMed ID: 38723817
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
